Literature DB >> 17099024

The relationship between FEV1 and peak expiratory flow in patients with airways obstruction is poor.

Ashutosh N Aggarwal1, Dheeraj Gupta, Surinder K Jindal.   

Abstract

STUDY
OBJECTIVES: To evaluate the correlation between FEV1 and peak expiratory flow (PEF) values expressed as a percentage of their predicted value, and to assess factors influencing differences between the two measurements.
DESIGN: Cross-sectional.
SETTING: Pulmonary function laboratory at a tertiary-level teaching hospital in northern India. PARTICIPANTS: A total of 6,167 adult patients showing obstructive pattern on spirometry over a 6-year period.
INTERVENTIONS: None. MEASUREMENTS AND
RESULTS: There was considerable variability between percentage of predicted FEV1 (FEV1%) and percentage of predicted PEF (PEF%). Locally weighted least-square modeling revealed that PEF% underestimated [corrected] FEV1% in patients with less severe obstruction and overestimated [corrected] it in those with more severe obstruction. Using Bland-Altman analysis, PEF% underestimated FEV1% by a mean of only 0.7%; however, limits of agreement were wide (- 27.4 to + 28.8%), indicating that these two measurements cannot be used interchangeably. PEF% and FEV1% were > 5% apart in approximately three fourths and differed by > 10% in approximately one half of the patients. On multivariate analysis, discordance > 5% was significantly influenced by female gender (odds ratio, 1.26; 95% confidence interval [CI], 1.01 to 1.58) and increasing FEV1% (odds ratio, 1.09 for every 10% increase; 95% CI, 1.04 to 1.14) but not by height or age.
CONCLUSIONS: FEV1% and PEF% are not equivalent in many patients, especially women and those with less severe airflow limitation. Assumptions of parity between PEF% and FEV1% must be avoided.

Entities:  

Mesh:

Year:  2006        PMID: 17099024     DOI: 10.1378/chest.130.5.1454

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  16 in total

1.  Spirometry in primary care for case finding and management of chronic obstructive pulmonary disease primary care diagnostic technology update.

Authors:  Gary Parkes; Annette Plüddemann; Carl Heneghan; Christopher P Price; Jane Wolstenholme; Matthew Thompson
Journal:  Br J Gen Pract       Date:  2011-11       Impact factor: 5.386

2.  Prediction of forced expiratory volume in pulmonary function test using radial basis neural networks and k-means clustering.

Authors:  Sujatha C Manoharan; Swaminathan Ramakrishnan
Journal:  J Med Syst       Date:  2009-10       Impact factor: 4.460

3.  Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations.

Authors:  Ritesh Agarwal; Sahajal Dhooria; Ashutosh Nath Aggarwal; Venkata N Maturu; Inderpaul S Sehgal; Valliappan Muthu; Kuruswamy T Prasad; Lakshmikant B Yenge; Navneet Singh; Digambar Behera; Surinder K Jindal; Dheeraj Gupta; Thanagakunam Balamugesh; Ashish Bhalla; Dhruva Chaudhry; Sunil K Chhabra; Ramesh Chokhani; Vishal Chopra; Devendra S Dadhwal; George D'Souza; Mandeep Garg; Shailendra N Gaur; Bharat Gopal; Aloke G Ghoshal; Randeep Guleria; Krishna B Gupta; Indranil Haldar; Sanjay Jain; Nirmal K Jain; Vikram K Jain; Ashok K Janmeja; Surya Kant; Surender Kashyap; Gopi C Khilnani; Jai Kishan; Raj Kumar; Parvaiz A Koul; Ashok Mahashur; Amit K Mandal; Samir Malhotra; Sabir Mohammed; Prasanta R Mohapatra; Dharmesh Patel; Rajendra Prasad; Pallab Ray; Jai K Samaria; Potsangbam Sarat Singh; Honey Sawhney; Nusrat Shafiq; Navneet Sharma; Updesh Pal S Sidhu; Rupak Singla; Jagdish C Suri; Deepak Talwar; Subhash Varma
Journal:  Lung India       Date:  2015-04

4.  Impact of Personal, Subhourly Exposure to Ultrafine Particles on Respiratory Health in Adolescents with Asthma.

Authors:  Ashley L Turner; Cole Brokamp; Chris Wolfe; Tiina Reponen; Patrick H Ryan
Journal:  Ann Am Thorac Soc       Date:  2022-09

5.  Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; V N Maturu; Sahajal Dhooria; K T Prasad; Inderpaul S Sehgal; Lakshmikant B Yenge; Aditya Jindal; Navneet Singh; A G Ghoshal; G C Khilnani; J K Samaria; S N Gaur; D Behera
Journal:  Lung India       Date:  2013-07

6.  Peak expiratory flow rate as a surrogate for forced expiratory volume in 1 second in COPD severity classification in Thailand.

Authors:  Chaicharn Pothirat; Warawut Chaiwong; Nittaya Phetsuk; Chalerm Liwsrisakun; Chaiwat Bumroongkit; Athavudh Deesomchok; Theerakorn Theerakittikul; Atikun Limsukon
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-06-25

7.  Once-daily fluticasone furoate 50 mcg in mild-to-moderate asthma: a 24-week placebo-controlled randomized trial.

Authors:  W W Busse; E D Bateman; P M O'Byrne; J Lötvall; A Woodcock; H Medley; R Forth; L Jacques
Journal:  Allergy       Date:  2014-08-22       Impact factor: 13.146

8.  137Cesium exposure and spirometry measures in Ukrainian children affected by the Chernobyl nuclear incident.

Authors:  Erik R Svendsen; Igor E Kolpakov; Yevgenia I Stepanova; Vitaliy Y Vdovenko; Maryna V Naboka; Timothy A Mousseau; Lawrence C Mohr; David G Hoel; Wilfried J J Karmaus
Journal:  Environ Health Perspect       Date:  2010-01-25       Impact factor: 9.031

9.  SLC26A9 SNP rs7512462 is not associated with lung disease severity or lung function response to ivacaftor in cystic fibrosis patients with G551D-CFTR.

Authors:  Alice C Eastman; Rhonda G Pace; Hong Dang; Melis Atalar Aksit; Briana Vecchio-Pagán; Anh-Thu N Lam; Wanda K O'Neal; Scott M Blackman; Michael R Knowles; Garry R Cutting
Journal:  J Cyst Fibros       Date:  2021-03-02       Impact factor: 5.527

10.  Logistic regression model for prediction of airway reversibility using peak expiratory flow.

Authors:  Javad Shakeri; Omalbanin Paknejad; Keivan Gohari Moghadam; Maryam Taherzadeh
Journal:  Tanaffos       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.